Search
Enter keywords, a title or a report id number below.
Oncology
-
- -
- - You are in Oncology category
- - You are in Oncology category
- -
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Leukemia
- Lymphoma
- Ovarian Cancer
- Colon Cancer
- Cervical Cancer
- Brain Cancer
- Bladder Cancer
The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?
Find out
... more
Sort by
Sorted by
Date Published
-
Triple Analysis: Lymphoma, Cancer Vaccines and Peptides
Bioseeker, Jan 2013 , Pages: 2626This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lymphoma), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area (Peptides).... -
Triple Analysis: Lung Cancer, Prostate Cancer and Peptides
Bioseeker, Jan 2013 , Pages: 3829This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Prostate Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated... -
Triple Analysis: Lymphoma, Protein Kinase Inhibitors and Peptides
Bioseeker, Jan 2013 , Pages: 4907This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lymphoma), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific... -
Triple Analysis: Lung Cancer, Pancreatic Cancer and Peptides
Bioseeker, Jan 2013 , Pages: 3439This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Pancreatic Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated... -
Triple Analysis: Melanoma, Pancreatic Cancer and Peptides
Bioseeker, Jan 2013 , Pages: 2893This triple analysis focuses on cancer drug development strategies in both Melanoma and Pancreatic Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated... -
Triple Analysis: Lung Cancer, Protein Kinase Inhibitors and Peptides
Bioseeker, Jan 2013 , Pages: 5276This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lung Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific... -
Triple Analysis: Lung Cancer, Antibodies and Peptides
Bioseeker, Jan 2013 , Pages: 4697This triple analysis focuses on cancer drug development strategies in Lung Cancer and by the two compound strategies of Antibodies and Peptides. Each of these three individual parts is evaluated according... -
Triple Analysis: Melanoma, Apoptosis and Peptides
Bioseeker, Jan 2013 , Pages: 3407This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect area (Apoptosis) and one compound specific area (Peptides).... -
Triple Analysis: Pancreatic Cancer, Angiogenesis and Peptides
Bioseeker, Jan 2013 , Pages: 3820This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Pancreatic Cancer), one mechanism/target/effect area (Angiogenesis) and one compound specific area... -
Triple Analysis: Prostate Cancer, Angiogenesis and Peptides
Bioseeker, Jan 2013 , Pages: 4210This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Prostate Cancer), one mechanism/target/effect area (Angiogenesis) and one compound specific area... -
Triple Analysis: Pancreatic Cancer, Protein Kinase Inhibitors and Peptides
Bioseeker, Jan 2013 , Pages: 5056This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Pancreatic Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound... -
Triple Analysis: Cancer Vaccines, Protein Kinase Inhibitors and Peptides
Bioseeker, Jan 2013 , Pages: 4612This triple analysis focuses on cancer drug development strategies by the two mechanism/target/effect areas of Cancer Vaccines and Protein Kinase Inhibitors and by the compound strategy of Peptides.... -
Triple Analysis: Protein Kinase Inhibitors, Antibodies and Peptides
Bioseeker, Jan 2013 , Pages: 6314This triple analysis focuses on cancer drug development strategies by the mechanism/target/effect of Protein Kinase Inhibitors and by the two compound strategies of Antibodies and Peptides. Each of... -
Triple Analysis: Cancer Vaccines, Antibodies and Peptides
Bioseeker, Jan 2013 , Pages: 4033This triple analysis focuses on cancer drug development strategies by the mechanism/target/effect of Cancer Vaccines and by the two compound strategies of Antibodies and Peptides. Each of these three... -
Triple Analysis: Melanoma, Prostate Cancer and Peptides
Bioseeker, Jan 2013 , Pages: 3283This triple analysis focuses on cancer drug development strategies in both Melanoma and Prostate Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated according... -
Triple Analysis: Melanoma, Protein Kinase Inhibitors and Peptides
Bioseeker, Jan 2013 , Pages: 4730This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific... -
Triple Analysis: Melanoma, Antibodies and Peptides
Bioseeker, Jan 2013 , Pages: 4151This triple analysis focuses on cancer drug development strategies in Melanoma and by the two compound strategies of Antibodies and Peptides. Each of these three individual parts is evaluated according... -
Triple Analysis: Prostate Cancer, Cancer Vaccines and Peptides
Bioseeker, Jan 2013 , Pages: 3165This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Prostate Cancer), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area... -
Triple Analysis: Pancreatic Cancer, Cancer Vaccines and Peptides
Bioseeker, Jan 2013 , Pages: 2775This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Pancreatic Cancer), one mechanism/target/effect area (Cancer Vaccines) and one compound specific... -
Triple Analysis: Lung Cancer, Apoptosis and Peptides
Bioseeker, Jan 2013 , Pages: 3953This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lung Cancer), one mechanism/target/effect area (Apoptosis) and one compound specific area (Peptides).... -
Triple Analysis: Pancreatic Cancer, Antibodies and Peptides
Bioseeker, Jan 2013 , Pages: 4477This triple analysis focuses on cancer drug development strategies in Pancreatic Cancer and by the two compound strategies of Antibodies and Peptides. Each of these three individual parts is evaluated... -
Triple Analysis: Melanoma, Angiogenesis and Peptides
Bioseeker, Jan 2013 , Pages: 3494This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect area (Angiogenesis) and one compound specific area (Peptides).... -
Triple Analysis: Angiogenesis, Protein Kinase Inhibitors and Peptides
Bioseeker, Jan 2013 , Pages: 5657This triple analysis focuses on cancer drug development strategies by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors and by the compound strategy of Peptides. Each... -
Triple Analysis: Prostate Cancer, Protein Kinase Inhibitors and Peptides
Bioseeker, Jan 2013 , Pages: 5446This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Prostate Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound... -
Triple Analysis: Prostate Cancer, Antibodies and Peptides
Bioseeker, Jan 2013 , Pages: 4867This triple analysis focuses on cancer drug development strategies in Prostate Cancer and by the two compound strategies of Antibodies and Peptides. Each of these three individual parts is evaluated... -
Triple Analysis: Angiogenesis, Cancer Vaccines and Peptides
Bioseeker, Jan 2013 , Pages: 3376This triple analysis focuses on cancer drug development strategies by the two mechanism/target/effect areas of Angiogenesis and Cancer Vaccines and by the compound strategy of Peptides. Each of these... -
Triple Analysis: Pancreatic Cancer, Apoptosis and Peptides
Bioseeker, Jan 2013 , Pages: 3733This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Pancreatic Cancer), one mechanism/target/effect area (Apoptosis) and one compound specific area... -
Triple Analysis: Prostate Cancer, Apoptosis and Peptides
Bioseeker, Jan 2013 , Pages: 4123This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Prostate Cancer), one mechanism/target/effect area (Apoptosis) and one compound specific area (Peptides).... -
Triple Analysis: Apoptosis, Cancer Vaccines and Peptides
Bioseeker, Jan 2013 , Pages: 3289This triple analysis focuses on cancer drug development strategies by the two mechanism/target/effect areas of Apoptosis and Cancer Vaccines and by the compound strategy of Peptides. Each of these three... -
Triple Analysis: Angiogenesis, Antibodies and Peptides
Bioseeker, Jan 2013 , Pages: 5078This triple analysis focuses on cancer drug development strategies by the mechanism/target/effect of Angiogenesis and by the two compound strategies of Antibodies and Peptides. Each of these three individual... -
Triple Analysis: Leukemia, Antibodies and Peptides
Bioseeker, Jan 2013 , Pages: 4521This triple analysis focuses on cancer drug development strategies in Leukemia and by the two compound strategies of Antibodies and Peptides. Each of these three individual parts is evaluated according... -
Triple Analysis: Lung Cancer, Melanoma and Peptides
Bioseeker, Jan 2013 , Pages: 3113This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Melanoma and by the compound strategy of Peptides. Each of these three individual parts is evaluated according... -
Triple Analysis: Lymphoma, Melanoma and Peptides
Bioseeker, Jan 2013 , Pages: 2744This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the compound strategy of Peptides. Each of these three individual parts is evaluated according... -
Triple Analysis: Lymphoma, Prostate Cancer and Peptides
Bioseeker, Jan 2013 , Pages: 3460This triple analysis focuses on cancer drug development strategies in both Lymphoma and Prostate Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated according... -
Triple Analysis: Colorectal Cancer, Leukemia and Peptides
Bioseeker, Jan 2013 , Pages: 3216This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Leukemia and by the compound strategy of Peptides. Each of these three individual parts is evaluated... -
Triple Analysis: Breast Cancer, Lung Cancer and Peptides
Bioseeker, Jan 2013 , Pages: 4091This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Lung Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated according... -
Triple Analysis: Breast Cancer, Melanoma and Peptides
Bioseeker, Jan 2013 , Pages: 3545This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Melanoma and by the compound strategy of Peptides. Each of these three individual parts is evaluated according... -
Triple Analysis: Breast Cancer, Antibodies and Peptides
Bioseeker, Jan 2013 , Pages: 5129This triple analysis focuses on cancer drug development strategies in Breast Cancer and by the two compound strategies of Antibodies and Peptides. Each of these three individual parts is evaluated according... -
Triple Analysis: Breast Cancer, Pancreatic Cancer and Peptides
Bioseeker, Jan 2013 , Pages: 3871This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Pancreatic Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated... -
Triple Analysis: Breast Cancer, Cancer Vaccines and Peptides
Bioseeker, Jan 2013 , Pages: 3427This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Breast Cancer), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area... -
Triple Analysis: Colorectal Cancer, Lung Cancer and Peptides
Bioseeker, Jan 2013 , Pages: 3392This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Lung Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated... -
Triple Analysis: Breast Cancer, Apoptosis and Peptides
Bioseeker, Jan 2013 , Pages: 4385This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Breast Cancer), one mechanism/target/effect area (Apoptosis) and one compound specific area (Peptides).... -
Triple Analysis: Breast Cancer, Angiogenesis and Peptides
Bioseeker, Jan 2013 , Pages: 4472This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Breast Cancer), one mechanism/target/effect area (Angiogenesis) and one compound specific area (Peptides).... -
Triple Analysis: Colorectal Cancer, Melanoma and Peptides
Bioseeker, Jan 2013 , Pages: 2846This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Melanoma and by the compound strategy of Peptides. Each of these three individual parts is evaluated... -
Triple Analysis: Colorectal Cancer, Lymphoma and Peptides
Bioseeker, Jan 2013 , Pages: 3023This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Lymphoma and by the compound strategy of Peptides. Each of these three individual parts is evaluated... -
Triple Analysis: Colorectal Cancer, Antibodies and Peptides
Bioseeker, Jan 2013 , Pages: 4430This triple analysis focuses on cancer drug development strategies in Colorectal Cancer and by the two compound strategies of Antibodies and Peptides. Each of these three individual parts is evaluated... -
Triple Analysis: Colorectal Cancer, Prostate Cancer and Peptides
Bioseeker, Jan 2013 , Pages: 3562This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Prostate Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated... -
Triple Analysis: Leukemia, Melanoma and Peptides
Bioseeker, Jan 2013 , Pages: 2937This triple analysis focuses on cancer drug development strategies in both Leukemia and Melanoma and by the compound strategy of Peptides. Each of these three individual parts is evaluated according... -
Triple Analysis: Leukemia, Pancreatic Cancer and Peptides
Bioseeker, Jan 2013 , Pages: 3263This triple analysis focuses on cancer drug development strategies in both Leukemia and Pancreatic Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated... -
Triple Analysis: Leukemia, Lung Cancer and Peptides
Bioseeker, Jan 2013 , Pages: 3483This triple analysis focuses on cancer drug development strategies in both Leukemia and Lung Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated according...
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
